InflaRx N.V.
USD2.24
-0.04 (-1.75%)
CEO
Niels C. Riedemann
IPO Date
2017-11-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
DE
Open
$2.21
Prev. Close
$2.28
Day Low
$2.13
Day High
$2.42
52W Low
$0.74
52W High
$2.95
Market Cap
$0.16B
Volume
1.60M
| -3.1 |
| 31 Dec 2023 | FY | -743.7% | -67630.7% | -41.6% | -35.5% | 0.01 | 6.50 | -1.9 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -33.4% | -28.8% | 0.02 | 7.48 | -4.3 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -43.3% | -36.5% | 0.01 | 5.10 | -3.8 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -43.6% | -38.5% | 0.01 | 8.54 | -3.3 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -49.7% | -43.8% | 0.01 | 8.46 | -1.7 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -19.7% | -18.7% | 0.00 | 20.39 | -26.7 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -20.3% | -19.5% | 0.00 | 26.01 | -16.4 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | 34.8% | -30.3% | -2.08 | 16.83 | -37.3 |
| -1.4 |
| 30 Sept 2025 | Q3 | 98.6% | -51452.3% | -27.0% | -18.8% | 0.02 | 3.33 | -1.6 |
| 30 Jun 2025 | Q2 | -5985.4% | -36559.8% | -25.3% | -19.6% | 0.01 | 4.10 | -0.8 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -11.8% | -9.6% | 0.01 | 5.28 | -1.8 |
| 31 Dec 2024 | Q4 | 666984.2% | 1208456.7% | -8.3% | -6.7% | 0.01 | 5.06 | -6.9 |
| 30 Sept 2024 | Q3 | 158.6% | -14092.9% | -26.7% | -21.9% | 0.01 | 5.31 | -1.2 |
| 30 Jun 2024 | Q2 | -5376.7% | -217803.1% | -16.9% | -14.9% | 0.01 | 8.91 | -1.7 |
| 31 Mar 2024 | Q1 | -511.9% | -26798.1% | -10.2% | -9.0% | 0.01 | 8.90 | -2.2 |
| 31 Dec 2023 | Q4 | -12023.6% | -696857.2% | -15.5% | -13.3% | 0.01 | 6.50 | -1.4 |